Evidence map›Paper›PMID 39382295›Full record

ArticlemBio2024

The alphaherpesvirus gE/gI glycoprotein complex and proteases jointly orchestrate invasion across the host's upper respiratory epithelial barrier.

E Van Crombrugge, X Ren, S Glorieux, I Zarak, W Van den Broeck, C Bachert, N Zhang, T Van Zele, D Kim, G A Smith and 2 more

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

E Van CrombruggeDepartment of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Laboratory of Virology, Ghent University, Merelbeke, Belgium.ORCID 0000-0002-9257-5025
X RenDepartment of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Laboratory of Virology, Ghent University, Merelbeke, Belgium.
S GlorieuxCenter for Human Body Material, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
I ZarakDepartment of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Laboratory of Virology, Ghent University, Merelbeke, Belgium.
W Van den BroeckDepartment of Morphology, Imaging, Orthopedics, Rehabilitation and Nutrition, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
C BachertDepartment of Otorhinolaryngology - Head and Neck Surgery, University Hospital of Münster, Münster, Germany.
N ZhangDepartment of Head and Skin, Upper Airways Research Laboratory, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
T Van ZeleDepartment of Head and Skin, Upper Airways Research Laboratory, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
D KimDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
G A SmithDepartment of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0001-9644-8472
K Laval *Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Laboratory of Virology, Ghent University, Merelbeke, Belgium.ORCID 0000-0002-6873-4110
H Nauwynck *Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Laboratory of Virology, Ghent University, Merelbeke, Belgium.

Funding

Alpha-Herpesvirus Transport on AxonsR01AI056346 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SMITH, GREGORY ALLAN · 2004 to 2024
$6.8M
Fonds Wetenschappelijk Onderzoek (FWO) G035920NNIAID NIH HHS R01 AI056346UGent | Bijzonder Onderzoeksfonds UGent (BOF) 01D15319UGent | Bijzonder Onderzoeksfonds UGent (BOF) BOF23/GOA/015
6 · The paper itself

Abstract

Alphaherpesviruses, including herpes simplex virus type 1 (HSV-1), pseudorabies virus (PRV), and bovine herpesvirus type 1 (BoHV-1), are significant pathogens affecting humans and animals. These viruses penetrate the upper respiratory tract mucosa, yet the mechanisms facilitating this invasion are not fully understood. This study investigates the role of the gE/gI glycoprotein complex and proteases in mucosal invasion by these viruses. Using species-specific respiratory mucosal explants, we observed that the removal of extracellular calcium disrupts epithelial junction integrity, enhancing viral infection across all viruses and suggesting a common mechanism of targeting a basolaterally located receptor. PRV exhibited significantly faster replication and deeper invasion compared to HSV-1 and BoHV-1. The gE glycoprotein was consistently polarized at the basement membrane across all viruses, indicating a critical role in the process of viral entry and subsequent spread through the epithelium. In this context, "infection" refers to the virus's attachment to its cell-surface receptor, entry into the cell, and completion of the viral life cycle, culminating in the production of progeny virions. Notably, in gE/gI null mutants of PRV and HSV-1, while the infection was not abortive and the viral life cycle was completed, the infection was delayed, and the invasion into the deeper layers of the epithelium and underlying mucosa was significantly reduced. In BoHV-1 mutants, this effect was even more pronounced, with infection restricted to the apical cells, failing to progress to the basal cells. In addition, PRV and HSV-1 invasion involved serine protease activity, unlike BoHV-1, which correlates with its slower invasion pace. Notably, the protease facilitating PRV invasion was identified as a urokinase plasminogen activator (uPA), while the specific protease for HSV-1 remains unidentified. These findings highlight the critical roles of the gE/gI complex and proteases in alphaherpesvirus pathogenesis, offering potential targets for therapeutic intervention. IMPORTANCE: Herpes simplex virus type 1 (HSV-1) infections are a worldwide issue. More than three billion people are infected with HSV-1 globally. Although most infections with HSV-1 occur subclinically, severe symptoms and complications are numerous and can be life-threatening. Complications include encephalitis and blindness. Recently, HSV-1 infections have been associated with the development of Alzheimer's Disease. To date, no effective vaccines against HSV-1 are on the market. Pseudorabies virus (PRV) and bovine herpesvirus type 1 (BoHV-1) are two alphaherpesviruses of major veterinary importance. Although efforts have been made to eradicate these viruses from livestock animals, clinical problems still occur, resulting in great economic losses for farmers. It is evident that new insights into the pathogenesis of alphaherpesviruses are needed, to develop effective treatments and novel preventive therapies.

Indexed as

Herpesvirus 1, HumanVirus InternalizationAnimalsCattleEpithelial CellsHerpesviridae InfectionsHerpesvirus 1, BovineHerpesvirus 1, SuidHumansPeptide HydrolasesRespiratory MucosaViral Envelope ProteinsVirus ReplicationPeptide HydrolasesViral Envelope ProteinsalphaherpesvirusgE/gI complexpathogenesis, mucosa invasionproteasesupper respiratory tracturokinase plasminogen activator

Identifiers

PMID39382295
PMCPMC11558996

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.